-
Characterizing the Contribution of RWE in Healthcare Decision-Making in Oncology
Mar 10, 2025, 14:00 PM -
Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study
Mar 10, 2025, 14:00 PM -
Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy
Mar 10, 2025, 14:00 PM -
Impact of Increased Patients' Out-of-Pocket Costs on Oral Anticoagulant Discontinuation among Medicare Beneficiaries with Atrial Fibrillation Treated with Apixaban
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review and Meta-Analysis of Clinical Outcomes Across Five Malignant Procedures for Robotic-Assisted Surgery with the Da Vinci Single Port Surgical System
Mar 10, 2025, 14:00 PM -
Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)
Mar 10, 2025, 14:00 PM -
Patient Journey Prior to the Diagnosis of Niemann-Pick Disease Type C
Mar 10, 2025, 14:00 PM -
The Dynamic Nature of Network Meta-Analysis: How Data Updates Could Influence Health Technology Assessment
Mar 10, 2025, 14:00 PM -
Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US
Mar 10, 2025, 14:00 PM -
Inpatient Hospitalization Trends for COPD in 2018 versus 2021 in United States: A Retrospective Analysis
Mar 10, 2025, 14:00 PM -
Cost-effectiveness Analysis of Ferric Carboxymaltose (Renegy®) for the Treatment of Iron Deficiency Anemia During Pregnancy: The Mexican Social Security Institute (IMSS) Perspective
Mar 10, 2025, 14:00 PM -
Cost-Utility of Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Disease Prevention Among Colombian Infants
Mar 10, 2025, 14:00 PM -
Travel Burden of Beta-Thalassemia Patients Receiving Red Blood Cell Transfusions in the Brazilian Public Healthcare System: A Real-World Study
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Healthcare Resource Use (HRU) in Patients With Metastatic Melanoma (mMEL) Treated With BRAF-MEK Inhibitor Targeted Therapies (TTs)
Mar 10, 2025, 14:00 PM -
Review of Cell Therapy Access Landscape
Mar 10, 2025, 14:00 PM -
Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts
Mar 10, 2025, 14:00 PM -
Evaluating the Application of GPT-4o and Retrieval-Augmented Generation (RAG) for Assessing Risk of Bias and Study Quality in Systematic Literature Reviews (SLRs): Preliminary Findings from a Comparative Study
Mar 10, 2025, 14:00 PM -
Spillover Effects of Medical Innovations: A Generic and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
Mar 10, 2025, 14:00 PM -
A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England
Mar 10, 2025, 14:00 PM -
Healthcare Costs Associated With Adverse Events During Treatment Episodes for Pediatric Attention-Deficit/Hyperactivity Disorder
Mar 10, 2025, 14:00 PM